|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 3/05/15 Organovo Holdings, Inc. 8-K:7,9 3/05/15 2:2.8M RRD ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 19K 2: EX-99 Ex-99.1 HTML 19K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 5, 2015
ORGANOVO HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 001-35996
|
Delaware |
|
27-1488943 |
|
(State or other jurisdiction of incorporation) |
|
(I.R.S. Employer Identification No.) |
|
6275 Nancy Ridge Dr., |
|
(Address of principal executive offices, including zip code) |
|
(858) 550-9994 |
|
(Registrant’s telephone number, including area code) |
|
|
|
|
|
(Former Name or Former Address, if Changed Since Last Report) |
|
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |
|
|
|
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure.
On March 5, 2015, Keith Murphy, the President and Chief Executive Officer of Organovo Holdings, Inc. (the “Company”), will be participating in a live webcast presentation to investors via http://RetailInvestorConferences.com. During the webcast, Mr. Murphy intends to provide a business update, including an update on the commercial launch of the Company’s exVive3D Liver, Bioprinted Human Tissue and a discussion of the commercialization milestones for the Company’s 3D bioprinted kidney tissue. The presentation will take place at 12:15 p.m. Eastern Standard Time, and investors may access the presentation at http://retailinvestorconferences.com > click on red “register / watch event now” button.
The presentation will be a live, interactive online event where investors are invited to ask questions in real-time - both in the presentation hall as well as the Company’s “virtual trade booth.” A copy of the presentation slides is attached hereto as Exhibit 99.1. If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available at http://retailinvestorconferences.com for 90 days.
The information furnished on this Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits.
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Presentation Slides, dated March 5, 2015. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
ORGANOVO HOLDINGS, INC. |
|
|
|
|
|
|
|
Date: March 5, 2015 |
|
/s/ Keith Murphy |
|
|
|
|
|
|
|
|
|
Chief Executive Officer |
|
|
Exhibit No. |
|
Description |
|
|
|
|
|
99.1 |
|
Presentation Slides, dated March 5, 2015. |
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period End: | 3/5/15 | None on these Dates | ||
| List all Filings | ||||